New Adeno-Associated Virus Strategies to Support Momentum in the Clinic
- 1 May 2011
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 22 (5), 519-521
- https://doi.org/10.1089/hum.2011.4080
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Systemic Elimination ofde novoCapsid Protein Synthesis from Replication-Competent AAV Contamination in the LiverHuman Gene Therapy, 2011
- A Simple Method to Increase the Transduction Efficiency of Single-Stranded Adeno-Associated Virus VectorsIn VitroandIn VivoHuman Gene Therapy, 2011
- A Versatile Adeno-Associated Virus Vector Producer Cell Line Method for Scalable Vector Production of Different SerotypesHuman Gene Therapy, 2011
- Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical TrialHuman Gene Therapy, 2011
- Mycophenolate Mofetil Impairs Transduction of Single-Stranded Adeno-Associated Viral VectorsHuman Gene Therapy, 2011
- Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune ResponsesMolecular Therapy, 2009
- Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivoGene Therapy, 2008
- Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverBlood, 2007
- Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseNature Medicine, 2006
- A Novel Gene Expression Control System and Its Use in Stable, High-Titer 293 Cell-Based Adeno-Associated Virus Packaging Cell LinesJournal of Virology, 2002